Psychemedics Corporation

(NASDAQ:PMD)

Latest On Psychemedics Corporation (PMD):

Date/Time Type Description Signal Details
2023-05-24 05:51 ESTDividendA dividend of $0.07 has been announced on May 9, 2023. It will be paid Jun 8, 2023 with an ex-dividend date of May 24, 2023.Neutral
2023-05-10 06:23 ESTNewsPsychemedics GAAP EPS of -$0.07, revenue of $5.9MN/A
2023-03-30 05:56 ESTDividendA dividend of $0.07 has been announced on Mar 21, 2023. It will be paid Apr 10, 2023 with an ex-dividend date of Mar 30, 2023.Neutral
2023-03-22 00:24 ESTNewsPsychemedics GAAP EPS of -$0.12, revenue of $5.7MN/A
2022-12-01 04:51 ESTDividendA dividend of $0.07 has been announced on Nov 9, 2022. It will be paid Dec 16, 2022 with an ex-dividend date of Dec 1, 2022.Neutral
2022-11-10 04:43 ESTNewsPsychemedics GAAP EPS of -$0.02, revenue of $6.5MN/A
2022-08-23 05:51 ESTDividendA dividend of $0.07 has been announced on Aug 9, 2022. It will be paid Sep 9, 2022 with an ex-dividend date of Aug 23, 2022.Neutral
2022-08-10 04:38 ESTNewsPsychemedics GAAP EPS of -$0.06, revenue of $6.51MN/A
2022-08-10 04:38 ESTNewsPsychemedics declares $0.07 dividendN/A
2022-05-26 05:51 ESTDividendA dividend of $0.07 has been announced on Nov 30, -0001. It will be paid Jun 24, 2022 with an ex-dividend date of May 26, 2022.Neutral
2022-05-11 08:11 ESTNewsPsychemedics GAAP EPS of $0.01, revenue of $6.5MN/A
2022-04-26 01:38 ESTNewsPsychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery PlayN/A
2022-03-30 06:07 ESTNewsPsychemedics GAAP EPS of -$0.29, revenue of $6.44MN/A
2021-12-17 04:52 ESTDividendA dividend of $0.05 has been announced on Dec 10, 2021. It will be paid Dec 30, 2021 with an ex-dividend date of Dec 17, 2021.Neutral
2021-12-10 20:52 ESTNewsPsychemedics declares $0.05 dividendN/A
2021-11-18 21:27 ESTNewsPsychemedics: Q3 Revenues +29%, Margins Surge, Possible Corporate Actions Including DividendN/A
2021-10-18 19:38 ESTNewsPsychemedics: Market Leader, 8% FCF Yield, Possible Takeover TargetN/A
2021-01-30 16:05 ESTNewsPsychemedics Corp.: Trucking Along Into A Potential Big Catalyst ($21 PT)N/A
2020-11-26 21:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 05:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 22:47 ESTNewsPsychemedics reports Q3 resultsN/A
2020-11-08 00:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:51 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 13:46 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:51 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 17:31 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:50 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 23:18 ESTNewsPsychemedics reports Q2 resultsN/A
2020-08-06 13:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:28 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 18:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:43 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:30 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 13:23 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:25 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:48 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 05:56 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 01:32 ESTFinancialsCompany financials have been released.Neutral
2020-05-17 17:47 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 00:46 ESTNewsPsychemedics reports Q1 resultsN/A
2020-05-06 06:02 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 05:31 ESTFinancialsCompany financials have been released.Neutral
2020-04-12 09:34 ESTNewsPsychemedics reports Q4 resultsN/A
2020-04-12 09:29 ESTNewsPsychemedics goes ex-dividend tomorrowN/A
2020-04-09 05:24 ESTStock SplitA stock split has occured on Aug 1, 2002 with a split factor of 1:4.Neutral
2020-04-03 21:31 ESTFinancialsCompany financials have been released.Neutral
2020-03-01 00:24 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 04:45 ESTFinancialsCompany financials have been released.Neutral

About Psychemedics Corporation (PMD):

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.

PMD Quotes by TradingView

See Advanced Chart

General

  • Name Psychemedics Corporation
  • Symbol PMD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 204
  • Last Split Factor1:4
  • Last Split Date2002-08-01
  • Fiscal Year EndDecember
  • IPO Date1994-02-17
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Providers & Services
  • Gic SubIndustryHealth Care Services
  • Web URLhttp://www.psychemedics.com
View More

Valuation

  • Trailing PE 37.07
  • Price/Sales (Trailing 12 Mt.) 1.65
  • Price/Book (Most Recent Quarter) 3.15
  • Enterprise Value Revenue 1.95
  • Enterprise Value EBITDA 6.31
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Profit Margin -16%
  • Operating Margin -19%
  • Return on Assets -12%
  • Return on Equity -25%
  • Revenue 24.74 million
  • Earnings Per Share $0.14
  • Revenue Per Share $4.48
  • Gross Profit 16.44 million
  • Quarterly Earnings Growth -47.5%
View More

Highlights

  • Market Capitalization 36.54 million
  • EBITDA 224000
  • Analyst Target Price $32
  • Book Value Per Share $2.34
View More

Share Statistics

  • Shares Outstanding 5.53 million
  • Shares Float 4.2 million
  • % Held by Insiders 1617%
  • % Held by Institutions 42.64%
  • Shares Short 22340
  • Shares Short Prior Month 17773
  • Short Ratio 0.43
View More

Technicals

  • Beta 0.85
  • 52 Week High $7.9
  • 52 Week Low $3.58
  • 50 Day Moving Average 7.22
  • 200 Day Moving Average 5.23
View More

Dividends

  • Forward Annual Dividend Rate $0.72
  • Forward Annual Dividend Yield 13.74%
  • Dividend Date 2020-03-03
  • ExDividend Date 2020-02-20
  • Dividend Per Share $0.36
  • Dividend Yield 2.75%
View More

Psychemedics Corporation (PMD) Dividend Calendar:

Psychemedics Corporation pays an annual dividend of $0.72 per share, with a dividend yield of 2.75%.
PMD's last dividend payment was made to shareholders on March 3, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Psychemedics Corporation (PMD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-09$5.17 million-$0.20
2020-06-302020-09-30$N/A-$0.20
2020-03-312020-06-30$7.54 million-$0.37
2019-12-312020-03-31$8.72 million-$0.03
2019-09-302019-12-31$9.85 million-$0.10
2019-06-302019-09-30$9.29 million$0.12
2019-03-312019-06-30$9.82 million$0.14
2018-12-312019-03-31$9.94 million$0.11
2018-09-302018-12-31$11.02 million$0.16
2018-06-302018-09-30$10.79 million$0.23
2018-03-312018-06-30$10.94 million$0.21
2017-12-312018-03-31$9.76 million$0.23
2017-09-302017-12-31$10.05 million$0.42
2017-06-302017-09-30$9.68 million$0.25
2017-03-312017-06-30$10.21 million$0.16
2016-12-312017-03-31$10.76 million$0.27
2016-09-302016-12-31$11.85 million$0.43
2016-06-302016-09-30$9.7 million$0.49
2016-03-312016-06-30$6.67 million$0.30
2015-12-312016-03-31$6.13 million$-0.00
2015-09-302015-12-31$7.08 million$0.03
2015-06-302015-09-30$7 million$0.15
2015-03-312015-06-30$6.76 million$0.05
2014-12-312015-03-31$6.76 million$0.05$0.08-37.5%
2014-09-302014-12-31$7.7 million$0.13$0.124.83%
2014-06-302014-09-30$7.69 million$0.17$0.03466.67%
2014-03-312014-06-30$7.05 million$0.16$0.1233.33%
2013-12-312014-03-31$6.48 million$0.14$0.1216.67%
2013-09-302013-12-31$7.06 million$0.16$0.20-18.35%
2013-06-302013-09-30$6.9 million$0.20$0.194.21%
2013-03-312013-06-30$6.43 million$0.20
2012-12-312013-03-31$5.66 million$0.16
2012-09-302012-12-31$6.46 million$0.05
2012-06-302012-09-30$6.86 million$0.17
2012-03-312012-06-30$6.24 million$0.19
2011-12-312012-03-31$5.55 million$0.16
2011-09-302011-12-31$6.32 million$0.08
2011-06-302011-09-30$6.23 million$0.21
2011-03-312011-06-30$6 million$0.21
2010-12-312011-03-31$5.12 million$0.16
2010-09-302010-12-31$5.11 million$0.08$0.12-33.33%
2010-06-302010-08-10$5.42 million$0.17$0.1070%
2010-03-312010-05-11$4.46 million$0.10$0.11-9.09%
2009-12-312010-02-23$4.27 million$0.10$0.0742.86%
2009-09-302009-11-03$4.67 million$0.15$0.03400%
2009-06-302009-08-04$3.94 million$0.03$0.04-25%
2009-03-312009-05-07$4.08 million$0.01$0.12-91.67%
2008-12-312009-02-19$4.82 million$0.03
2008-09-302008-11-04$6.21 million$0.17
2008-06-302008-07-28$6.21 million$0.20
2008-03-312008-04-30$5.71 million$0.17
2007-12-312008-02-15$5.89 million$0.17
2007-09-302007-10-31$6.46 million$0.23
2007-06-302007-08-06$6.5 million$0.25
2007-03-312007-05-03$5.72 million$0.20
2006-12-312007-02-13$5.8 million$0.22
2006-09-302006-10-30$6.38 million$0.27
2006-06-302006-08-01$6.18 million$0.27
2006-03-312006-05-02$5.07 million$0.18
2005-12-312006-02-08$5.08 million$0.18
2005-09-302005-10-27$5.35 million$0.19
2005-06-302005-08-01$5.62 million$0.23
2005-03-312005-05-02$5.34 million$0.18
2004-12-312005-03-07$4.56 million$0.11
2004-09-302004-10-27$4.87 million$0.16
2004-06-302004-08-03$5.35 million$0.19
2004-03-312004-05-10$4.16 million$0.09
2003-12-312004-02-18$3.91 million$0.07$0.070%
2003-09-302003-11-03$4.17 million$0.07
2003-06-302003-08-05$4.27 million$0.08
2003-03-312003-03-31$3.66 million$0.02
2002-09-302002-09-30$4.35 million$0.08
2002-06-302002-06-30$4.79 million$0.12
2002-03-312002-03-31$3.57 million$0.01
2001-09-302001-09-30$3.96 million$0.02
2001-06-302001-06-30$4.52 million$0.06
2001-03-312001-03-31$4.06 million$0.00
2000-09-302000-11-08$5.02 million$0.08$0.12-33.33%
2000-06-302000-08-04$5.47 million$0.12$0.120%
2000-03-312000-05-10$4.68 million$0.12$0.16-25%
1999-12-312000-02-10$0.04$0.08-50%
1999-09-301999-11-04$0.12$0.16-25%
1999-06-301999-07-26$0.16$0.1233.33%
1999-03-311999-03-31$0.10
1998-09-301998-11-03$0.12$0.120%
1998-06-301998-06-30$0.14
1998-03-311998-03-31$0.11

Psychemedics Corporation (PMD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development 305000 N/A 331000 354000 393000
Income Before Tax -1.43 million N/A -315000 -602000 1.34 million
Selling General Administrative 2.24 million N/A 2.64 million 3.74 million 2.66 million
Gross Profit 1.13 million N/A 2.73 million 3.49 million 4.38 million
Ebit -1.41 million N/A -242000 -606000 1.33 million
Operating Income -1.41 million N/A -242000 -606000 1.33 million
Income Tax Expense N/A -1.3 million N/A -72000 663000
Total Revenue 5.17 million N/A 7.54 million 8.72 million 9.85 million
Cost of Revenue 4.04 million N/A 4.81 million 5.23 million 5.47 million
Total Other Income Expense Net -17000 N/A -73000 4000 6000
Net Income From Continuing Operations -1.11 million N/A -159000 -530000 677000
Net Income Applicable to Common Shares N/A -2.05 million N/A -530000 677000
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A -344000 N/A N/A N/A
Change to Liabilities N/A -1.13 million N/A N/A 93000
Total Cash Flow from Investing Activities N/A -344000 N/A N/A -826000
Net Borrowings N/A 2.01 million N/A N/A -105000
Total Cash Flow from Financial Activities N/A 2 million N/A N/A -1.1 million
Change to Operating Activities N/A -2.19 million N/A N/A 719000
Change in Cash N/A -1.66 million N/A N/A -605000
Total Cash from Operating Activities N/A -3.32 million N/A N/A 1.67 million
Depreciation N/A 907000 N/A N/A 718000
Other Cash Flow from Investing Activities N/A N/A N/A N/A -61000
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A 998000 N/A N/A -645000
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A 141000 N/A N/A 109000
Capital Expenditures N/A 344000 N/A N/A 731000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 11.04 million 11.85 million 9.4 million 10.71 million 8.76 million
Total Stockholder Equity 12.94 million 13.92 million 15.81 million 16.82 million 18.02 million
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets 23.98 million 25.78 million 25.21 million 27.53 million 26.78 million
Common Stock N/A 31000 N/A 31000 31000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -8.06 million -6.96 million -4.91 million -3.75 million -2.23 million
Other Liabilities N/A 476000 N/A 550000 817000
Other Assets N/A 920000 N/A 943000 944000
Cash 1.81 million 3.67 million 5.33 million 7.28 million 6.49 million
Total Current Liabilities 3.34 million 3.28 million 4.91 million 5.84 million 4.69 million
Other Stockholder Equity N/A -1.63 million N/A -1.62 million -1.7 million
Property, Plant & Equipment N/A 15.1 million N/A 13.74 million 12.35 million
Total Current Assets 8.83 million 9.75 million 10.78 million 12.85 million 13.49 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets N/A 13.92 million N/A 16.82 million 18.02 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt 3.62 million 3.79 million 1.78 million 1.95 million 900000
Inventory N/A N/A N/A N/A N/A
Accounts Payable 416000 61000 1.23 million 617000 372000

Psychemedics Corporation (PMD) Chart:

Psychemedics Corporation (PMD) News:

Below you will find a list of latest news for Psychemedics Corporation (PMD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Psychemedics Corporation (PMD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Psychemedics Corporation (PMD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000150514820000007/0001505148-20-000007-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000088458920000018/0000884589-20-000018-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000103328418000048/0001033284-18-000048-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000103328418000049/0001033284-18-000049-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000103328418000050/0001033284-18-000050-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000103738918000148/0001037389-18-000148-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000103738919000222/0001037389-19-000222-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000103738920000244/0001037389-20-000244-index.htm
2017-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000114420417036707/0001144204-17-036707-index.htm
2017-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000114420417040217/0001144204-17-040217-index.htm
2017-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000114420417040516/0001144204-17-040516-index.htm
2017-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000114420417053870/0001144204-17-053870-index.htm
2017-10-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000114420417054244/0001144204-17-054244-index.htm
2017-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000114420417058317/0001144204-17-058317-index.htm
2018-01-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184318000676/0001171843-18-000676-index.htm
2018-02-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184318001330/0001171843-18-001330-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184318001759/0001171843-18-001759-index.htm
2018-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/806517/000117184318002060/0001171843-18-002060-index.htm
2018-03-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/806517/000117184318002146/0001171843-18-002146-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184318003003/0001171843-18-003003-index.htm
2018-04-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184318003112/0001171843-18-003112-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184318003588/0001171843-18-003588-index.htm
2018-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184318005380/0001171843-18-005380-index.htm
2018-07-2710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184318005470/0001171843-18-005470-index.htm
2018-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184318007127/0001171843-18-007127-index.htm
2018-10-2510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184318007223/0001171843-18-007223-index.htm
2019-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319000550/0001171843-19-000550-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319001480/0001171843-19-001480-index.htm
2019-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/806517/000117184319001481/0001171843-19-001481-index.htm
2019-03-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/806517/000117184319001822/0001171843-19-001822-index.htm
2019-03-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/806517/000117184319001955/0001171843-19-001955-index.htm
2019-04-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/806517/000117184319002273/0001171843-19-002273-index.htm
2019-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319002562/0001171843-19-002562-index.htm
2019-04-2510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184319002627/0001171843-19-002627-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319003198/0001171843-19-003198-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319004725/0001171843-19-004725-index.htm
2019-07-2410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184319004764/0001171843-19-004764-index.htm
2019-08-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/806517/000117184319005455/0001171843-19-005455-index.htm
2019-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319006022/0001171843-19-006022-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319006697/0001171843-19-006697-index.htm
2019-10-2410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184319006773/0001171843-19-006773-index.htm
2019-12-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184319007977/0001171843-19-007977-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184320000683/0001171843-20-000683-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184320000878/0001171843-20-000878-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/806517/000117184320001248/0001171843-20-001248-index.htm
2020-02-2710-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/806517/000117184320001337/0001171843-20-001337-index.htm
2020-03-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/806517/000117184320002075/0001171843-20-002075-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/806517/000117184320002949/0001171843-20-002949-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/806517/000117184320002951/0001171843-20-002951-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184320003496/0001171843-20-003496-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184320003684/0001171843-20-003684-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184320003761/0001171843-20-003761-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184320003895/0001171843-20-003895-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184320005866/0001171843-20-005866-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/806517/000117184320005910/0001171843-20-005910-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/806517/000117184320006386/0001171843-20-006386-index.htm
2019-01-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000117266119000251/0001172661-19-000251-index.htm
2020-02-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000117266120000294/0001172661-20-000294-index.htm
2017-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000124067917000017/0001240679-17-000017-index.htm
2017-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000124067917000018/0001240679-17-000018-index.htm
2017-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000124067917000019/0001240679-17-000019-index.htm
2017-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000124067917000020/0001240679-17-000020-index.htm
2017-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000124067917000035/0001240679-17-000035-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000015/0001373894-19-000015-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000020/0001373894-19-000020-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000021/0001373894-19-000021-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000022/0001373894-19-000022-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000029/0001373894-19-000029-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000030/0001373894-19-000030-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000031/0001373894-19-000031-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000032/0001373894-19-000032-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000033/0001373894-19-000033-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000034/0001373894-19-000034-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000037/0001373894-19-000037-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000038/0001373894-19-000038-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000057/0001373894-19-000057-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000061/0001373894-19-000061-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000137389419000063/0001373894-19-000063-index.htm
2017-06-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000138195417000006/0001381954-17-000006-index.htm
2020-01-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000138195420000003/0001381954-20-000003-index.htm
2020-03-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000138195420000005/0001381954-20-000005-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000139834419002978/0001398344-19-002978-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/806517/000139834420003541/0001398344-20-003541-index.htm
2017-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000150514817000021/0001505148-17-000021-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000150514819000002/0001505148-19-000002-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000150514820000002/0001505148-20-000002-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000150514820000007/0001505148-20-000007-index.htm
2017-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000172260417000004/0001722604-17-000004-index.htm
2017-12-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000172260417000008/0001722604-17-000008-index.htm
2018-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000002/0001739481-18-000002-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000011/0001739481-18-000011-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000012/0001739481-18-000012-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000013/0001739481-18-000013-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000014/0001739481-18-000014-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000015/0001739481-18-000015-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000016/0001739481-18-000016-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000017/0001739481-18-000017-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000018/0001739481-18-000018-index.htm
2018-05-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000020/0001739481-18-000020-index.htm
2018-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000021/0001739481-18-000021-index.htm
2018-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000022/0001739481-18-000022-index.htm
2018-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000023/0001739481-18-000023-index.htm
2018-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000025/0001739481-18-000025-index.htm
2018-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000044/0001739481-18-000044-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/806517/000173948118000057/0001739481-18-000057-index.htm

Psychemedics Corporation (PMD) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Psychemedics Corporation (PMD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1617%
Institutional Ownership: 4264%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-12Neil LernerVP - FinanceSell1,412.0015.0621,264.7213,220.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000015/0001373894-19-000015-index.htm
2019-03-11Neil LernerVP - FinanceSell7,645.0015.11115,515.9514,632.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000015/0001373894-19-000015-index.htm
2019-05-03Neil LernerVP - FinanceBuy3,500.0016,419.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000038/0001373894-19-000038-index.htm
2019-06-14RAYMOND C JR KUBACKIChairman, CEO & PresidentBuy1,000.009.999,990.00176,374.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000063/0001373894-19-000063-index.htm
2017-11-14RAYMOND C JR KUBACKIChairman, CEO & PresidentBuy1,000.0016.8816,880.00178,228.00https://www.sec.gov/Archives/edgar/data/806517/000172260417000004/0001722604-17-000004-index.htm
2019-06-14MICHAEL I SCHAFFERVP of Laboratory OperationsSell3,900.009.6137,479.0019,169.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000061/0001373894-19-000061-index.htm
2018-05-22Neil LernerVP - FinanceSell1,879.0019.9937,561.2122,277.00https://www.sec.gov/Archives/edgar/data/806517/000173948118000025/0001739481-18-000025-index.htm
2019-06-13MICHAEL I SCHAFFERVP of Laboratory OperationsSell2,631.009.8225,836.4223,069.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000061/0001373894-19-000061-index.htm
2018-05-21Neil LernerVP - FinanceSell3,013.0020.1460,681.8224,156.00https://www.sec.gov/Archives/edgar/data/806517/000173948118000025/0001739481-18-000025-index.htm
2019-06-12MICHAEL I SCHAFFERVP of Laboratory OperationsSell2,800.009.8427,552.0025,700.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000061/0001373894-19-000061-index.htm
2018-05-03Neil LernerVP - FinanceBuy2,000.0027,451.00https://www.sec.gov/Archives/edgar/data/806517/000173948118000014/0001739481-18-000014-index.htm
2018-05-03FRED J WEINERTDirectorBuy1,000.0027,983.00https://www.sec.gov/Archives/edgar/data/806517/000173948118000017/0001739481-18-000017-index.htm
2019-05-03FRED J WEINERTDirectorBuy2,000.0028,583.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000030/0001373894-19-000030-index.htm
2018-09-06MICHAEL I SCHAFFERVP of Laboratory OperationsSell6,324.0019.23121,610.5228,624.00https://www.sec.gov/Archives/edgar/data/806517/000173948118000044/0001739481-18-000044-index.htm
2017-09-06MICHAEL I SCHAFFERVP of Laboratory OperationsSell2,167.0020.1443,643.3834,706.00https://www.sec.gov/Archives/edgar/data/806517/000124067917000035/0001240679-17-000035-index.htm
2017-09-05MICHAEL I SCHAFFERVP of Laboratory OperationsSell4,400.0020.3789,628.0036,873.00https://www.sec.gov/Archives/edgar/data/806517/000124067917000035/0001240679-17-000035-index.htm
2017-09-01MICHAEL I SCHAFFERVP of Laboratory OperationsSell981.0021.1620,757.9641,273.00https://www.sec.gov/Archives/edgar/data/806517/000124067917000035/0001240679-17-000035-index.htm
2017-05-10MICHAEL I SCHAFFERVP of Laboratory OperationsSell3,000.0020.4361,290.0042,447.00https://www.sec.gov/Archives/edgar/data/806517/000150514817000021/0001505148-17-000021-index.htm
2019-06-05Charles M DoucotVice President Sales & MktgBuy500.009.904,950.50500.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000057/0001373894-19-000057-index.htm
2018-05-03HARRY F SR CONNICKDirectorBuy3,400.0052,562.00https://www.sec.gov/Archives/edgar/data/806517/000173948118000018/0001739481-18-000018-index.htm
2019-05-03HARRY F SR CONNICKDirectorBuy6,550.0059,112.00https://www.sec.gov/Archives/edgar/data/806517/000137389419000029/0001373894-19-000029-index.htm